Cannabinoids in liver diseases.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Rastafarianism: When Religious Beliefs Conflict With Medical Necessity-A Case Report and Review of the Literature Around an Ethically Complicated Case.Case reports in psychiatry · 2025
   Article
2. Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.Journal of xenobiotics · 2023
   Article
3. Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.Frontiers in psychiatry · 2023
   Review
4. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.Nutrients · 2022
   Article
5. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.International journal of environmental research and public health · 2022
   Review
6. Cannabinoids and Chronic Liver Diseases.International journal of molecular sciences · 2022
   Review
7. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis.Archives of public health = Archives belges de sante publique · 2022
   Article
8. Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.Medical science monitor : international medical journal of experimental and clinical research · 2021
   Article
9. A Network Pharmacology Approach to Identify Potential Molecular Targets for Cannabidiol's Anti-Inflammatory Activity.Cannabis and cannabinoid research · 2021
   Article
10. Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease.Alcohol research : current reviews · 2021
    Review
11. The Potential Use of Cannabis in Tissue Fibrosis.Frontiers in cell and developmental biology · 2021
    Review
12. Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis.World journal of hepatology · 2020
    Article
13. Problematic Cannabis Use and Risk of Complications in Patients with Chronic Hepatitis C.Cureus · 2019
    Article
14. Hepatic microcirculation and mechanisms of portal hypertension.Nature reviews. Gastroenterology & hepatology · 2019
    Review
15. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.Nutrition and metabolic insights · 2019
    Article
16. The Role of Cannabinoids in the Setting of Cirrhosis.Medicines (Basel, Switzerland) · 2018
    Review
17. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.Medicines (Basel, Switzerland) · 2018
    Review
18. ΔJournal of lipid research · 2018
    Article
19. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.PloS one · 2017
    Article
20. Unmasking the Burden of Cannabis in Cirrhosis: A Propensity-Matched Real-World Analysis.Acta gastroenterologica Latinoamericana
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.